Invicta Diagnostic Limited (NSE:INVICTA)

India · Delayed Price · Currency is INR

60.50

-4.20 (-6.49%)

At close: Oct 23, 2026

Market Cap	760.60M
Revenue (ttm)	330.42M +1,038.3%
Net Income	49.06M
EPS	4.90
Shares Out	12.57M
PE Ratio	12.35
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,000
Open	62.05
Previous Close	64.70
Day's Range	60.00 - 62.05
52-Week Range	58.10 - 105.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 17, 2026

About Invicta Diagnostic

Invicta Diagnostic Limited owns and operates diagnostic centers under the PC Diagnostics brand name in India. The company offers radiology services, including MRI, CT scan, PET-CT, X-Ray, sonography, and other imaging services; and pathology services, such as clinical laboratory and pathological diagnostic investigations. It also provides integrated diagnostics comprising a combination of radiology and pathology services. In addition, the company offers technology-enabled services, including digital reporting and teleradiology-related services.... [Read more]

Industry Medical Laboratories

Founded 2016

Employees 131

Stock Exchange National Stock Exchange of India

Ticker Symbol INVICTA

Full Company Profile

Financial Performance

In fiscal year 2026, Invicta Diagnostic's revenue was 330.42 million, an increase of 9.48% compared to the previous year's 301.81 million. Earnings were 49.06 million, an increase of 0.30%.

Financial Statements